NEW YORK, November 7, 2024 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and ...
Quarter Results07.11.2024 / 12:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Immunic, Inc. Reports Third Quarter 2024 Financial Resultsand Provides Corporate Update– ...
Some 2million Americans suffer from celiac disease — where gluten causes severe damage to the gut ... although the Environmental Protection Agency currently says there is no evidence that the chemical ...
People with celiac disease, lupus, type 1 diabetes, and Sjögren’s syndrome can also be at risk of suffering from Hashimoto‘s disease. Diagnosis typically involves blood tests to measure levels of ...